Bachem Holding AG
(OTC: BCHMY)
|
2:13 PM UTC, 06/24/24 | |||
---|---|---|---|---|
Last: $9.00 | Change: +0.20 | %Change: +2.27% | Volume: 240 |
Open: | $ 9.00 | Volume: | 240 | |
---|---|---|---|---|
High: | $ 9.00 | Yield(%) | 0.59 | |
Low: | $ 9.00 | P/E Ratio (ttm): | 55.32 | |
Dividend ($): | 0.03 | Market Cap ($): | 6.91B | |
EPS ($) | n/a | Shares Out: | 749.74M |
% Price Change (last 4 weeks): | 6.64 |
---|---|
% Price Change (last 13 weeks): | 0.63 |
% Price Change (last 26 weeks): | 20.41 |
% Price Change (last 52 weeks): | 11.54 |
% Price Change (year to date): | 19.38 |
Return on Equity (%): | 8.79 |
---|---|
Return on Assets (%): | 7.12 |
Return on Invested Capital (%): | 11.50 |
Gross Profit Margin (%): | 30.65 |
---|---|
Net Profit Margin (%): | 19.38 |
Operating Profit Margin (%): | 22.27 |
|
|
50-day Moving Average: | $n/a |
---|---|
200-day Moving Average: | $n/a |
Avg. Daily Vol. (last 50 days): | n/a |
Avg. Daily Vol. (last 200 days): | n/a |
52-wk high: | $10.05 |
52-wk low: | $5.94 |
Bid: | $n/a |
Ask: | $n/a |
Bachem Holding AG engages in the provision of peptides and oligonucleotides. It operates through the Europe/Asia and North America geographical segments. It offers project management, research grade production, catalog peptides, peptide NCES, and commercial NCES. The company was founded in 2003 and is headquartered in Bubendorf, Switzerland.
|
Bachem Holding AG
Hauptstrasse 144 Bubendorf BL 4416 Phone: 41.58.595.20.21 Fax: 41.58.595.20.40 http://www.bachem.com |
Earnings (1year) ($): | n/a |
---|---|
Annual Dividend ($): | 0.05 |
Current P/E Ratio (ttm): | 55.32 |
Book Value ($): | 2.09 |
Cash Flow ($): | 0.22 |
Price/Earnings (x): | 55.32 |
---|---|
Price/Sales (x): | 8.98 |
Price/Book (x): | 3.69 |
Price/Cash Flow (x): | 20.67 |
Quick Ratio (x): | 3.04 |
---|---|
Current Ratio (x): | 5.11 |
LT Debt/Equity (x): | 0.02 |
Total Debt/Equity (x): | 0.03 |